Epigallocatechin gallate regulates the myeloid-specific transcription factor PU.1 in macrophages
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0301904 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Manjula Karpurapu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Davis Heart and Lung Research Institute, Critical Care and Sleep Medicine, Ohio State University Wexner Medical Center, Columb…. Hauptthemen laut MEDLINE: Catechin, Trans-Activators, Macrophages, Proto-Oncogene Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, American Heart Association, NHLBI Division of Intramural Research.
Abstract (Originalsprache)
Our previous research demonstrated that PU.1 regulates expression of the genes involved in inflammation in macrophages. Selective knockdown of PU.1 in macrophages ameliorated LPS-induced acute lung injury (ALI) in bone marrow chimera mice. Inhibitors that block the transcriptional activity of PU.1 in macrophages have the potential to mitigate the pathophysiology of LPS-induced ALI. However, complete inactivation of PU.1 gene disrupts normal myelopoiesis. Although the green tea polyphenol Epigallocatechin gallate (EGCG) has been shown to regulate inflammatory genes in various cell types, it is not known if EGCG alters the transcriptional activity of PU.1 protein. Using Schrodinger Glide docking, we have identified that EGCG binds with PU.1 protein, altering its DNA-binding and self-dimerization activity. In silico analysis shows that EGCG forms Hydrogen bonds with Glutamic Acid 209, Leucine 250 in DNA binding and Lysine 196, Tryptophan 193, and Leucine 182 in the self-dimerization domain of the PU.1 protein. Experimental validation using mouse bone marrow-derived macrophages (BMDM) confirmed that EGCG inhibits both DNA binding by PU.1 and self-dimerization. Importantly, EGCG had no impact on expression of the total PU.1 protein levels but significantly reduced expression of various inflammatory genes and generation of ROS. In summary, we report that EGCG acts as an inhibitor of the PU.1 transcription factor in macrophages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Davis Heart and Lung Research Institute, Critical Care and Sleep Medicine, Ohio State University Wexner Medical Center, Columbus, OH, United States of America.
- Mahavir Hospital and Research Center, Lakdikapul, Hyderabad, Telangana, India.
- Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, 214122, P.R. China.
- Department of Chemistry and Biochemistry, Ohio State University, Columbus, OH, United States of America.
ORCID-Profile: Manjula Karpurapu, John W Christman
Förderung
- NHLBI NIH HHS
- American Heart Association
- NHLBI Division of Intramural Research
- National Institute of General Medical Sciences
- Health Services Research Programme
Zitieren
APA
Karpurapu, M., Kakarala, K. K., Chung, S., Nie, Y., Koley, A., Dougherty, P., & Christman, J. W. (2024). Epigallocatechin gallate regulates the myeloid-specific transcription factor PU.1 in macrophages. PLOS ONE. https://doi.org/10.1371/journal.pone.0301904
Vancouver
Karpurapu M, Kakarala KK, Chung S, Nie Y, Koley A, Dougherty P, et al. Epigallocatechin gallate regulates the myeloid-specific transcription factor PU.1 in macrophages. PLOS ONE. 2024. doi:10.1371/journal.pone.0301904
BibTeX
@article{Karpurapu2024,
author = {Karpurapu, Manjula and Kakarala, Kavita Kumari and Chung, Sangwoon and Nie, Yunjuan and Koley, Amritendu and Dougherty, Patrick and Christman, John W},
title = {Epigallocatechin gallate regulates the myeloid-specific transcription factor PU.1 in macrophages},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0301904}
}
EUVIMED